Independent contract laboratory Bioassay will be participating and exhibiting next week in the 2nd Cell Therapy Potency Assay Summit, which will take place from 31 May to 2 June in Boston, Massachusetts.
The conference will gather more than 100 experts working to rationally design better potency assays to clear the path to regulatory approval and reduce hold times with scientifically rigorous and informative potency measurements. As part of Bioassay’s exhibition, Patrick Mäder, the company’s Head of Assay Development & Validation Study Director, will give a presentation about our expertise during the second day of the event entitled Bioassay: Power House for Potency Assays.
For more information about the conference or to register, please click here.